Tin tức & Cập nhật
Xem bài viết Gan
Xem
Chỉ hiển thị Multimedia

TACE + apatinib: A potential new strategy for intermediate/advanced HCC?
28 Dec 2022
bởiRoshini Claire Anthony
In patients with intermediate or advanced hepatocellular carcinoma (HCC), combining transarterial chemoembolization (TACE) with apatinib led to improvement in progression-free survival (PFS), according to a recent study from China.
28 Dec 2022







